Intratumoral injection of an adenovirus expressing interleukin 2 induces regression and immunity in a murine breast cancer model
- PMID: 7667323
- PMCID: PMC41189
- DOI: 10.1073/pnas.92.18.8522
Intratumoral injection of an adenovirus expressing interleukin 2 induces regression and immunity in a murine breast cancer model
Abstract
Rodent tumor cells engineered to secrete cytokines such as interleukin 2 (IL-2) or IL-4 are rejected by syngeneic recipients due to an enhanced antitumor host immune response. An adenovirus vector (AdCAIL-2) containing the human IL-2 gene has been constructed and shown to direct secretion of high levels of human IL-2 in infected tumor cells. AdCAIL-2 induces regression of tumors in a transgenic mouse model of mammary adenocarcinoma following intratumoral injection. Elimination of existing tumors in this way results in immunity against a second challenge with tumor cells. These findings suggest that adenovirus vectors expressing cytokines may form the basis for highly effective immunotherapies of human cancers.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
